Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Hepatology · Cirrhosis of the Liver

Living with Cirrhosis: Survivorship, Screening, and Nutrition

At a Glance

Living well with cirrhosis involves liver cancer surveillance every six months, individualized monitoring for swollen veins (varices) and bone loss, enough protein and calories with a late-evening snack, regular activity, medication review, recommended vaccines, and complete alcohol avoidance.

Living well with cirrhosis requires a proactive approach to monitoring and daily self-care. Because your liver is the body’s primary “processing plant” for nutrients and medications, your daily habits and long-term screening schedule are vital to preventing complications and maintaining your quality of life [1][2].

Long-Term Surveillance and Screening

Regular check-ups are essential to catch potential issues early, when they are most treatable.

  • Liver Cancer (HCC) Screening: You should have an abdominal ultrasound every 6 months [1]. This is surveillance, not a guarantee of early detection. Many experts now recommend combining this with a blood test called alpha-fetoprotein (AFP), which can improve the chances of finding small tumors early [3][4]. However, a normal AFP does not rule out cancer, and an elevated one does not diagnose it. If your ultrasound is “limited” or difficult to read (often due to obesity or the texture of the liver), your doctor may recommend a multiphasic MRI or CT scan instead [5][6].
  • Variceal Monitoring: Monitoring for swollen veins in the esophagus (varices) is increasingly tailored to your individual risk. If your liver stiffness is low and your platelet count is high, selected compensated patients may be able to safely delay or avoid an endoscopy [7]. However, this does not apply if you have decompensation or prior varices; you will need regular endoscopic check-ups or individualized beta-blocker therapy, as varices can recur even after treatment [8].
  • Bone Health: Cirrhosis significantly increases the risk of osteoporosis and fractures [9]. You should have a DXA scan (a bone density test) to screen for bone loss, especially if you are older, have cholestatic disease, steroid exposure, or prior fractures [10][11].

Nutrition and Fighting Muscle Loss

One of the greatest risks in cirrhosis is malnutrition and the loss of muscle mass, known as sarcopenia [2].

  • Protein and Calories: Current guidelines recommend a high-protein diet—typically 1.2 to 1.5 grams of protein per kilogram of body weight—and adequate calories (30–40 kcal/kg) to keep your muscles strong [2][12]. Important: Use dry, ideal, or adjusted body weight as actual weight overestimates needs if you have fluid or ascites. Seek individualized dietitian input.
  • The Late-Evening Snack: To prevent your body from breaking down its own muscle for energy during the night, it is highly recommended to eat a late-evening snack [2]. This helps bridge the long “fasting” period between dinner and breakfast [13].
  • Small, Frequent Meals: Aim for several small meals throughout the day rather than three large ones. This is easier on your digestion and provides a steady supply of energy [13].
  • Exercise: A combination of aerobic and resistance (weight-bearing) exercise is the best way to maintain muscle and improve your physical function [14][15]. Resistance exercise should be tailored for frailty, ascites, cardiopulmonary disease, or osteoporosis.

Medication Safety and Alcohol Abstinence

Because your liver and kidneys are more sensitive when you have cirrhosis, certain common medications can be dangerous [16].

  • NSAIDs and Aspirin: Do not self-start NSAIDs like ibuprofen (Advil, Motrin), naproxen (Aleve), and high-dose aspirin. They significantly increase the risk of kidney failure, internal bleeding, and fluid buildup in patients with cirrhosis [16]. However, if you are prescribed low-dose aspirin (e.g., for cardiovascular indications), do not stop it abruptly without the prescriber’s advice.
  • Use Caution with Sedatives: Sleeping pills, strong pain medicines (opioids), and some anti-anxiety medications (like benzodiazepines) can trigger confusion or hepatic encephalopathy [16][17].
  • Acetaminophen (Tylenol): Low doses of acetaminophen are often the safest choice for pain, but the maximum dose must be individualized (often capped at 2,000 mg/day), especially with alcohol use, malnutrition, or severe disease. Check combination products to avoid accidental overdose [16].
  • Complete Alcohol Abstinence: Regardless of etiology, continued alcohol use worsens outcomes. A direct, nonjudgmental recommendation to avoid alcohol completely is critical. If you drink heavily or are dependent, seek medical supervision to withdraw, as sudden cessation can be dangerous.
  • Vaccinations: Keep your immune system strong. Have a pharmacist/clinician reconcile your record for Hepatitis A and B, Influenza, COVID-19, Pneumococcal, and Shingles vaccines based on your age and local schedule. Although immune response may be lower, indicated vaccines are generally still recommended [18][19].

Common questions in this guide

How often should liver cancer be checked when I have cirrhosis?
People with cirrhosis are generally advised to have an abdominal ultrasound every six months to look for liver cancer. A blood test called alpha-fetoprotein may be added, but a normal result does not rule out cancer and a high result does not diagnose it. If ultrasound images are limited, your clinician may recommend a multiphasic MRI or CT scan.
Can I delay an endoscopy to check for esophageal varices?
The need for endoscopy depends on whether your cirrhosis is stable, your liver stiffness and platelet count, and whether you have had varices before. Some selected people with stable disease, low liver stiffness, and high platelets may safely delay or avoid endoscopy. People with decompensation or previous varices generally need regular endoscopic monitoring or individualized beta-blocker treatment.
How much protein and food energy do I need with cirrhosis?
Guidance often recommends about 1.2 to 1.5 grams of protein per kilogram of body weight and enough calories, usually 30 to 40 kilocalories per kilogram, to help prevent muscle loss. If you have fluid buildup or ascites, calculations should use dry, ideal, or adjusted weight rather than actual weight. A dietitian can tailor the plan to your needs.
What is the benefit of a bedtime snack with cirrhosis?
A small snack before bed helps reduce the long overnight fasting period, when the body may break down muscle for energy. Several small meals during the day can also provide a steadier supply of calories and protein. A dietitian can help choose a snack that fits your nutritional needs.
Which pain relievers can I safely take with cirrhosis?
Do not start ibuprofen, naproxen, or high-dose aspirin on your own because these medicines can raise the risk of kidney problems, bleeding, and fluid buildup. Low-dose aspirin prescribed for a cardiovascular reason should not be stopped without advice from the prescriber. Acetaminophen is often preferred at a clinician-set dose, commonly no more than 2,000 milligrams per day, and you should check combination products to prevent accidental overdose.
Is any alcohol safe after a cirrhosis diagnosis?
Complete alcohol avoidance is recommended with cirrhosis because continued drinking can worsen outcomes, regardless of the underlying cause. If you drink heavily or may be dependent on alcohol, seek medical supervision before stopping suddenly because withdrawal can be dangerous.
Which vaccines should I ask about if I have cirrhosis?
Ask a clinician or pharmacist to review whether you are up to date on hepatitis A and B, influenza, COVID-19, pneumococcal, and shingles vaccines. Recommendations depend on your age and local schedule, and a weaker immune response does not usually mean indicated vaccines should be skipped.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my most recent ultrasound, was the 'visualization' adequate? Should we consider an MRI if my BMI or liver type makes ultrasound difficult?
  2. 2.Am I getting enough protein and calories to prevent muscle loss? Can you recommend a specific late-evening snack that would be best for me?
  3. 3.Are all of my current medications safe for my liver? Are there any that need a lower dose because of my condition?
  4. 4.When is my next scheduled endoscopy, and do my liver stiffness and platelet count allow us to wait longer between screenings?
  5. 5.Have I received all the recommended vaccinations for someone with cirrhosis, including the latest pneumococcal and hepatitis shots?
  6. 6.What are my DXA scan results, and do I need to start treatment for osteoporosis or take specific vitamin D supplements?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis.

    Aby E, Phan J, Truong E, et al.

    Journal of clinical gastroenterology 2019; (53(2)):142-146 doi:10.1097/MCG.0000000000001075.

    PMID: 29912761
  2. 2

    A Systematic Review of Medical Nutrition Therapy Guidelines for Liver Cirrhosis: Do We Agree?

    Theodoridis X, Grammatikopoulou MG, Petalidou A, et al.

    Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 2020; (35(1)):98-107 doi:10.1002/ncp.10393.

    PMID: 31407834
  3. 3

    Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.

    Tzartzeva K, Obi J, Rich NE, et al.

    Gastroenterology 2018; (154(6)):1706-1718.e1 doi:10.1053/j.gastro.2018.01.064.

    PMID: 29425931
  4. 4

    Comparison of a multitarget blood test to ultrasound and alpha-fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta-analysis.

    Singal AG, Haaland B, Parikh ND, et al.

    Hepatology communications 2022; (6(10)):2925-2936 doi:10.1002/hep4.2045.

    PMID: 35945907
  5. 5

    Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.

    Sumida Y, Yoneda M, Seko Y, et al.

    Diagnostics (Basel, Switzerland) 2020; (10(8)) doi:10.3390/diagnostics10080579.

    PMID: 32785100
  6. 6

    Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis.

    Schoenberger H, Chong N, Fetzer DT, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022; (20(7)):1561-1569.e4 doi:10.1016/j.cgh.2021.06.012.

    PMID: 34119640
  7. 7

    Noninvasive assessment oesophageal varices: impact of the Baveno VI criteria.

    Bai W, Abraldes JG

    Current opinion in gastroenterology 2022; (38(3)):206-215 doi:10.1097/MOG.0000000000000824.

    PMID: 35645017
  8. 8

    Role of EUS evaluation after endoscopic eradication of esophageal varices with band ligation.

    Carneiro FO, Retes FA, Matuguma SE, et al.

    Gastrointestinal endoscopy 2016; (84(3)):400-7.

    PMID: 26905936
  9. 9

    Prevalent osteoporosis and fracture risk in patients with hepatic cirrhosis: a systematic review and meta-analysis.

    Shirinezhad A, Eshlaghi FM, Salabat D, et al.

    BMC gastroenterology 2025; (25(1)):115 doi:10.1186/s12876-025-03720-6.

    PMID: 40000980
  10. 10

    Bone microarchitecture and bone turnover in hepatic cirrhosis.

    Wakolbinger R, Muschitz C, Scheriau G, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2019; (30(6)):1195-1204 doi:10.1007/s00198-019-04870-6.

    PMID: 30788527
  11. 11

    Bone Health in Patients With Liver Diseases.

    Danford CJ, Trivedi HD, Bonder A

    Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2020; (23(2)):212-222 doi:10.1016/j.jocd.2019.01.004.

    PMID: 30744928
  12. 12

    Nutritional support in cirrhotic patients with sarcopenia.

    Vasques J, Guerreiro CS, Sousa J, et al.

    Clinical nutrition ESPEN 2019; (33()):12-17 doi:10.1016/j.clnesp.2019.07.011.

    PMID: 31451247
  13. 13

    [Nutrition in Liver Cirrhosis: Clinical Practice Recommendations].

    Plauth M

    Deutsche medizinische Wochenschrift (1946) 2019; (144(18)):1267-1274 doi:10.1055/a-0753-6081.

    PMID: 31514217
  14. 14

    Exercise and nutrition interventions for sarcopenia in cirrhosis: a systematic review and network meta-analysis of randomized controlled trials.

    Kittiprachakul S, Maung ST, Poorirerngpoom N, et al.

    European journal of clinical nutrition 2025; (79(11)):1087-1098 doi:10.1038/s41430-025-01642-w.

    PMID: 40925921
  15. 15

    Resistance exercise in combination with aerobic exercise reduces the incidence of serious events in patients with liver cirrhosis: a meta-analysis of randomized controlled trials.

    Kawaguchi T, Kawaguchi A, Hashida R, et al.

    Journal of gastroenterology 2024; (59(3)):216-228 doi:10.1007/s00535-023-02060-0.

    PMID: 38159112
  16. 16

    Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations.

    Weersink RA, Burger DM, Hayward KL, et al.

    Expert opinion on drug metabolism & toxicology 2020; (16(1)):45-57 doi:10.1080/17425255.2020.1702022.

    PMID: 31810397
  17. 17

    Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care.

    Bohra A, Worland T, Hui S, et al.

    World journal of gastroenterology 2020; (26(18)):2221-2231 doi:10.3748/wjg.v26.i18.2221.

    PMID: 32476788
  18. 18

    Vaccination in Chronic Liver Disease: An Update.

    Alukal JJ, Naqvi HA, Thuluvath PJ

    Journal of clinical and experimental hepatology 2022; (12(3)):937-947 doi:10.1016/j.jceh.2021.12.003.

    PMID: 34975241
  19. 19

    Real-world effectiveness of COVID-19 vaccination in liver cirrhosis: a systematic review with meta-analysis of 51,834 patients.

    Beran A, Mhanna A, Mhanna M, et al.

    Proceedings (Baylor University. Medical Center) 2023; (36(2)):151-156 doi:10.1080/08998280.2023.2165344.

    PMID: 36876272

This page is for informational purposes only and does not constitute medical advice about living with cirrhosis. Ask your clinician before changing medicines, diet, exercise, or alcohol use.

Get notified when new evidence is published on cirrhosis of liver.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.